Arrowstreet Capital
NVO

Arrowstreet Capital’s Novo Nordisk NVO Stock Holding History

Arrowstreet Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288M Buy
+7,827,491
New +$371M 0.16% 124
2025
Q2 		– Sell
-10,738
Closed -$746K – 2030
2025
Q1 		$746K Sell
10,738
-37,739
-78% -$3.12M ﹤0.01% 1539
2024
Q4 		$4.17M Sell
48,477
-402,326
-89% -$43.5M ﹤0.01% 1058
2024
Q3 		$8.02M Buy
450,803
+54,905
+14% +$7.32M 0.01% 822
2024
Q2 		$56.5M Buy
+395,898
New +$52.5M 0.05% 292
2024
Q1 		– Sell
-601,007
Closed -$62.2M – 1727
2023
Q4 		$62.2M Sell
601,007
-682,356
-53% -$67.5M 0.07% 231
2023
Q3 		$117M Buy
1,283,363
+660,881
+106% +$58.2M 0.14% 143
2023
Q2 		$50.4M Buy
622,482
+428,060
+220% +$35M 0.06% 248
2023
Q1 		$15.5M Buy
194,422
+172,982
+807% +$12.3M 0.02% 458
2022
Q4 		$1.45M Sell
21,440
-33,238
-61% -$1.95M ﹤0.01% 950
2022
Q3 		$2.72M Sell
54,678
-3,470,062
-98% -$186M ﹤0.01% 794
2022
Q2 		$196M Buy
3,524,740
+952,516
+37% +$52.9M 0.28% 100
2022
Q1 		$143M Buy
2,572,224
+728,744
+40% +$37.4M 0.18% 141
2021
Q4 		$103M Buy
1,843,480
+1,067,608
+138% +$57.8M 0.13% 183
2021
Q3 		$37.2M Buy
+775,872
New +$37.5M 0.05% 384
2021
Q1 		– Sell
-1,332,684
Closed -$46.5M – 2437
2020
Q4 		$46.5M Sell
1,332,684
-1,159,386
-47% -$40.1M 0.07% 297
2020
Q3 		$86.5M Sell
2,492,070
-3,624,124
-59% -$121M 0.14% 137
2020
Q2 		$200M Sell
6,116,194
-1,653,778
-21% -$52.8M 0.37% 43
2020
Q1 		$234M Sell
7,769,972
-217,468
-3% -$6.48M 0.66% 25
2019
Q4 		$231M Sell
7,987,440
-362,022
-4% -$10M 0.54% 35
2019
Q3 		$216M Sell
8,349,462
-310,074
-4% -$7.84M 0.5% 46
2019
Q2 		$221M Sell
8,659,536
-3,957,594
-31% -$97.8M 0.49% 52
2019
Q1 		$330M Sell
12,617,130
-545,596
-4% -$13.4M 0.78% 24
2018
Q4 		$303M Buy
13,162,726
+8,480,928
+181% +$188M 0.79% 27
2018
Q3 		$110M Sell
4,681,798
-1,156,302
-20% -$28.2M 0.25% 98
2018
Q2 		$135M Buy
5,838,100
+1,402,420
+32% +$33.3M 0.33% 81
2018
Q1 		$109M Sell
4,435,680
-668,808
-13% -$17.6M 0.25% 107
2017
Q4 		$137M Buy
5,104,488
+3,948,258
+341% +$100M 0.33% 81
2017
Q3 		$27.8M Buy
+1,156,230
New +$26.1M 0.07% 234
2017
Q2 		– Sell
-18,600
Closed -$319K – 1255
2017
Q1 		$319K Buy
+18,600
New +$324K ﹤0.01% 1146
2016
Q4 		– Sell
-636,400
Closed -$13.2M – 2270
2016
Q3 		$13.2M Buy
636,400
+360,000
+130% +$8.93M 0.04% 383
2016
Q2 		$7.43M Sell
276,400
-5,457,584
-95% -$150M 0.02% 497
2016
Q1 		$155M Sell
5,733,984
-10,021,598
-64% -$268M 0.66% 26
2015
Q4 		$458M Buy
15,755,582
+2,028,866
+15% +$56.2M 2.11% 4
2015
Q3 		$372M Buy
13,726,716
+2,238,474
+19% +$63.4M 1.77% 5
2015
Q2 		$315M Buy
11,488,242
+4,514,120
+65% +$127M 1.78% 5
2015
Q1 		$186M Sell
6,974,122
-4,931,578
-41% -$114M 1.15% 12
2014
Q4 		$252M Buy
11,905,700
+3,852,238
+48% +$86M 1.44% 9
2014
Q3 		$192M Buy
8,053,462
+4,859,898
+152% +$112M 1.03% 17
2014
Q2 		$73.8M Buy
+3,193,564
New +$70.5M 0.38% 61
2014
Q1 		– Sell
-1,310,760
Closed -$24.2M – 1276
2013
Q4 		$24.2M Sell
1,310,760
-423,940
-24% -$7.39M 0.13% 160
2013
Q3 		$29.4M Sell
1,734,700
-771,480
-31% -$13M 0.19% 130
2013
Q2 		$38.8M Buy
+2,506,180
New +$41.7M 0.29% 88

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrowstreet Capital's NVO Position: Q1 2026 in Review

Arrowstreet Capital opened a new position in Novo Nordisk (NVO) in Q1 2026: 7,827,491 shares worth $288M. The stake represents 0.16% of the portfolio and ranks #124 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in NVO as recently as Q1 2025.

Arrowstreet Capital first reported a position in NVO in Q2 2013 and has held it in 43 quarters since. The position peaked at $458M in Q4 2015. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Arrowstreet Capital held 7,827,491 shares of Novo Nordisk worth $288M as of Q1 2026.
  • Novo Nordisk was a new Arrowstreet Capital position in Q1 2026.
  • Novo Nordisk made up 0.16% of Arrowstreet Capital's portfolio in Q1 2026, its #124 holding.
  • Arrowstreet Capital first reported a position in Novo Nordisk in Q2 2013 and has held it in 43 quarters since.
  • Arrowstreet Capital's Novo Nordisk position peaked at $458M in Q4 2015.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.